Market

Significantly expands NRM capability through two opiates manufacturing facilities in Australia

From April 2016, the trivalent polio vaccine that is currently administered will be replaced by the bivalent variety to reduce…

To develop and commercialise pioneering neuroscience treatments

Valeant said that it would make an upfront payment of $100 million to AstraZeneca

The Rs 850 crore company expects to see organic growth of 15-20 per cent

The think tank likely to be set up within the next two months

Strengthening/ up-gradation of the system will be spread over a period of three years, both at the central and the state levels at…

Novartis will make an initial payment of $300 million to GSK for the acquisition of the compound

Department of Science and Technology to fund research on impact of yoga

Inspectors found ‘significant violations’ in its three manufacturing facilities in Bengaluru